Company / Return on Assets (ROA)
NovoCure Ltd Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-16.9%
FY2025
5-year range
-18.1% / -5.1%
FY2021-FY2025
Trend
-24.7%
vs FY2024
Sector context
#138 of 158
Health Care
What the data says
NovoCure Ltd's return on assets (roa) of -16.9% is lower than 87% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -46.7% in FY2016 to 1.9% in FY2020.
Based on SEC 10-K filings.
-16.9% in FY2025 with a 5-year CAGR of -18.8%.
Improved from -18.1% to -16.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -9.2pp
- 5-Year Change
- -18.8pp
- 10-Year Change
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 158This company -16.9% Sector average -2.2%
▼
-684.9% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 24.7% year-over-year.
- Currently 14.8pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -16.9% | -24.7% |
| FY2024 | -13.6% | +24.8% |
| FY2023 | -18.1% | -132.4% |
| FY2022 | -7.8% | -51.8% |
| FY2021 | -5.1% | -372.3% |
| FY2020 | 1.9% | +224.5% |
| FY2019 | -1.5% | +91.9% |
| FY2018 | -18.7% | +19.5% |
| FY2017 | -23.2% | +50.3% |
| FY2016 | -46.7% | -28.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026